- Home
- ECOR vs GNTA Comparison
ECOR vs GNTA Comparison
Compare ECOR & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- GNTA
- Stock Information
- Founded
- ECOR 2005
- GNTA 2014
- Country
- ECOR United States
- GNTA Italy
- Employees
- ECOR N/A
- GNTA N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ECOR Health Care
- GNTA Health Care
- Exchange
- ECOR Nasdaq
- GNTA Nasdaq
- Market Cap
- ECOR 40.1M
- GNTA 70.8M
- IPO Year
- ECOR 2018
- GNTA 2021
- Fundamental
- Price
- ECOR $5.19
- GNTA $4.22
- Analyst Decision
- ECOR Strong Buy
- GNTA Strong Buy
- Analyst Count
- ECOR 2
- GNTA 1
- Target Price
- ECOR $25.50
- GNTA $25.00
- AVG Volume (30 Days)
- ECOR 122.7K
- GNTA 6.9K
- Earning Date
- ECOR 05-07-2025
- GNTA 01-01-0001
- Dividend Yield
- ECOR N/A
- GNTA N/A
- EPS Growth
- ECOR N/A
- GNTA N/A
- EPS
- ECOR N/A
- GNTA N/A
- Revenue
- ECOR $25,182,000.00
- GNTA N/A
- Revenue This Year
- ECOR $32.20
- GNTA N/A
- Revenue Next Year
- ECOR $46.27
- GNTA N/A
- P/E Ratio
- ECOR N/A
- GNTA N/A
- Revenue Growth
- ECOR 57.09
- GNTA N/A
- 52 Week Low
- ECOR $5.02
- GNTA $2.79
- 52 Week High
- ECOR $19.49
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ECOR 31.29
- GNTA 59.59
- Support Level
- ECOR $6.01
- GNTA $3.84
- Resistance Level
- ECOR $7.14
- GNTA $4.25
- Average True Range (ATR)
- ECOR 0.80
- GNTA 0.25
- MACD
- ECOR 0.07
- GNTA 0.04
- Stochastic Oscillator
- ECOR 3.99
- GNTA 95.95
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.